{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:49:49Z","timestamp":1792050589985,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018047","name":"NRG Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ijrobp.2021.10.138","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T22:36:46Z","timestamp":1635892606000},"page":"1115-1122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology\/RTOG 0526)"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0711-3318","authenticated-orcid":false,"given":"Juanita","family":"Crook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Pisansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard J.","family":"Trabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahul B.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.","family":"Murtha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vigneault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Helou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff M.","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Mack","family":"Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashesh B.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Raben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Sandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.10.138_bib0001","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/JU.0000000000000110","article-title":"Long-term implications of a positive posttreatment biopsy in patients treated with external beam radiotherapy for clinically localized prostate cancer","volume":"201","author":"Zelefsky","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0002","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.juro.2007.11.063","article-title":"Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer","volume":"179","author":"Zelefsky","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0003","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.eururo.2008.04.076","article-title":"Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: What can they teach us?","volume":"55","author":"Zapatero","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0004","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0360-3016(02)02977-2","article-title":"Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: Analysis of a prostate cancer randomized radiation dose escalation trial","volume":"54","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2005.06.002","article-title":"A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy","volume":"76","author":"Nichol","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0006","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.urolonc.2013.12.014","article-title":"Underutilization of local salvage therapy after radiation therapy for prostate cancer","volume":"32","author":"Tran","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0007","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-4295(98)00492-0","article-title":"Salvage brachytherapy for localized prostate cancer after radiotherapy failure","volume":"53","author":"Grado","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0008","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0090-4295(99)00241-1","article-title":"Permanent brachytherapy as salvage treatment for recurrent prostate cancer","volume":"54","author":"Beyer","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0009","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.juro.2006.07.008","article-title":"Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation","volume":"176","author":"Wong","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.brachy.2009.01.004","article-title":"Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study","volume":"8","author":"Nguyen","year":"2009","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0011","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncr.23161","article-title":"Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes","volume":"112","author":"Agarwal","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0012","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijrobp.2018.09.039","article-title":"A Prospective phase II trial of trans-perineal ultrasound-guided brachytherapy for locally recurrent prostate cancer after external beam radiotherapy","volume":"103","author":"Crook","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0013","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.brachy.2018.08.008","article-title":"Using a surgical prostate-specific antigen threshold of >0.2 ng\/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial","volume":"17","author":"Morris","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0014","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1470-2045(14)70040-3","article-title":"Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: Long-term results from the MRC RT01 randomised controlled trial","volume":"15","author":"Dearnaley","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0016","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.2009.25.8475","article-title":"Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group\/American College of Radiology 95-09","volume":"28","author":"Zietman","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0017","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","article-title":"70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial","volume":"80","author":"Beckendorf","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0018","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.02.045","article-title":"Dose escalation for prostate adenocarcinoma: A long-term update on the outcomes of a phase 3, single institution randomized clinical trial","volume":"104","author":"Pasalic","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0019","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2018.0587","article-title":"Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9-10 prostate cancer","volume":"319","author":"Kishan","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0020","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.brachy.2015.02.389","article-title":"Combination therapy improves prostate cancer survival for patients with potentially lethal prostate cancer: The impact of Gleason pattern 5","volume":"14","author":"Liss","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0021","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0022","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ijrobp.2007.11.066","article-title":"Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes","volume":"71","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0023","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijrobp.2007.03.065","article-title":"Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: Magnetic resonance imaging and step-section pathology evidence","volume":"69","author":"Pucar","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0024","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.eururo.2010.12.012","article-title":"Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer","volume":"60","author":"Williams","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0025","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00345-012-0982-2","article-title":"Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: Update from the COLD registry","volume":"31","author":"Spiess","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0026","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ijrobp.2019.07.012","article-title":"Salvage stereotactic body radiation therapy for local prostate cancer recurrence after radiation therapy: A Retrospective multicenter study of the GETUG","volume":"105","author":"Pasquier","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0027","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijrobp.2019.10.014","article-title":"Retreatment for local recurrence of prostatic carcinoma after prior therapeutic irradiation: Efficacy and toxicity of HDR-like SBRT","volume":"106","author":"Fuller","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0028","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/bju.13766","article-title":"Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients","volume":"119","author":"Crouzet","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0029","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.eururo.2012.01.022","article-title":"Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: A systematic review of the literature","volume":"61","author":"Chade","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<81::AID-CNCR12>3.0.CO;2-2","article-title":"Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma","volume":"79","author":"Crook","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0031","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2007.05.047","article-title":"Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy","volume":"70","author":"Buyyounouski","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0032","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ijrobp.2013.03.028","article-title":"Interval to biochemical failure predicts clinical outcomes in patients with high-risk prostate cancer treated by combined-modality radiation therapy","volume":"86","author":"Shilkrut","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0033","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cncr.22941","article-title":"Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: A systematic review of the literature","volume":"110","author":"Nguyen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0034","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1097\/01.ju.0000157569.59229.72","article-title":"Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer","volume":"173","author":"D'Amico","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0035","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2967\/jnumed.117.196683","article-title":"Treatment outcomes from (68)Ga-PSMA PET\/CT-informed salvage radiation treatment in men with rising PSA after radical prostatectomy: Prognostic value of a negative PSMA PET","volume":"58","author":"Emmett","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0036","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00259-017-3711-7","article-title":"Diagnostic performance of (68)Ga-PSMA-11 (HBED-CC) PET\/CT in patients with recurrent prostate cancer: Evaluation in 1007 patients","volume":"44","author":"Afshar-Oromieh","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0037","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2967\/jnumed.115.160382","article-title":"Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET\/CT in Prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy","volume":"56","author":"Morigi","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0038","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brachy.2013.11.005","article-title":"A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy","volume":"13","author":"Yamada","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0039","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1177\/1533034617741797","article-title":"Focal MRI-guided salvage high-dose-rate brachytherapy in patients with radiorecurrent prostate cancer","volume":"16","author":"Maenhout","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0040","first-page":"20","article-title":"Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer","volume":"23","author":"Slevin","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0041","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/cncr.22560","article-title":"Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: Analysis of Radiation Therapy Oncology Group study 0019","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.10.138_bib0042","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/cncr.26203","article-title":"Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: Long-term results of CALGB 99809","volume":"117","author":"Hurwitz","year":"2011","journal-title":"Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621030480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621030480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:00:42Z","timestamp":1759744842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301621030480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0360301621030480"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.10.138","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology\/RTOG 0526)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.10.138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}